查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1967900

2026-2034年全球感染疾病呼吸系统疾病诊断市场规模、份额、趋势和成长分析报告

Global Infectious Respiratory Disease Diagnostics Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年，感染疾病呼吸道疾病诊断市场规模将从 2025 年的 577.4 亿美元成长至 939.7 亿美元，2026 年至 2034 年的复合年增长率为 5.56%。

由于包括流感、肺炎、结核病和其他病毒性疾病在内的呼吸道感染疾病日益普遍，全球感染疾病呼吸道疾病诊断市场正稳定扩张。都市化、空气污染和季节性疫情爆发显着推动了诊断需求。各国政府和医疗机构正优先建立早期检测和监测系统，以防止感染扩散。分子诊断技术的进步，包括聚合酶炼式反应（PCR）和快速抗原检测，提高了检测的准确性并加快了检测速度。此外，新兴国家检测基础设施的改善也加速了市场渗透。

人们对预防医学和定期体检的日益重视进一步推动了市场成长。医院、诊所和诊断检查室正在投资自动化多功能检测平台，以有效应对不断增长的患者数量。人口老化加剧了呼吸道感染疾病的可及性。

对研发的持续投入维持了市场前景的稳健。就地检验和家用诊断试剂盒的推广可望提升患者的便利性和可及性。人工智慧驱动的诊断解决方案有望提高诊断的准确性和预测能力。亚太地区和拉丁美洲地区的新兴经济体蕴藏着巨大的成长机会。总体而言，在技术创新和全球健康倡议的支持下，该市场有望实现长期持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球感染疾病呼吸道疾病诊断市场：依产品分类

  • 市场分析、洞察与预测
  • 设备（影像检查、呼吸检测设备及其他设备）
  • 消耗品
  • 服务

第五章 全球感染疾病呼吸道疾病诊断市场：依样本划分

  • 市场分析、洞察与预测
  • 唾液
  • 鼻咽拭子（NPS）
  • 前鼻区
  • 血
  • 其他的

第六章 全球感染疾病呼吸道疾病诊断市场：依应用划分

  • 市场分析、洞察与预测
  • COVID-19
  • 流感
  • 呼吸道融合细胞病毒（RSV）
  • 结核
  • 链球菌检测
  • 其他呼吸系统疾病检查

第七章 全球感染疾病呼吸道疾病诊断市场：依技术划分

  • 市场分析、洞察与预测
  • 免疫检测
  • 分子诊断
  • 微生物学
  • 其他技术

第八章 全球感染疾病呼吸道疾病诊断市场：依最终用途划分

  • 市场分析、洞察与预测
  • 医院
  • 诊断检查室
  • 医生诊所
  • 其他的

第九章 全球感染疾病呼吸道疾病诊断市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第十章 竞争格局

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十一章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Abbott
    • Thermo Fisher Scientific Inc
    • Koninklijke Philips NV
    • F. Hoffmann-La Roche Ltd
    • BD
    • BioMAfA（C）Rieux SA
    • Bio-Rad Laboratories Inc
    • Quidel Corporation
    • Siemens Healthcare GmbH
    • Danaher
    • Qiagen
简介目录
Product Code: VMR11219207

The Infectious Respiratory Disease Diagnostics Market size is expected to reach USD 93.97 Billion in 2034 from USD 57.74 Billion (2025) growing at a CAGR of 5.56% during 2026-2034.

The Global Infectious Respiratory Disease Diagnostics Market is expanding steadily due to the rising prevalence of respiratory infections such as influenza, pneumonia, tuberculosis, and other viral diseases. Increasing urbanization, air pollution, and seasonal outbreaks are significantly contributing to diagnostic demand. Governments and healthcare institutions are prioritizing early detection and surveillance systems to prevent widespread transmission. Technological advancements in molecular diagnostics, including PCR and rapid antigen testing, are enhancing accuracy and turnaround time. Additionally, improved laboratory infrastructure in emerging economies is accelerating market penetration.

Growing awareness regarding preventive healthcare and routine screening programs is further strengthening market growth. Hospitals, clinics, and diagnostic laboratories are investing in automated and multiplex testing platforms to handle higher patient volumes efficiently. The aging population, which is more susceptible to respiratory infections, also drives consistent testing demand. Integration of digital health systems and data analytics improves disease tracking and outbreak management. Increasing collaborations between public health agencies and private diagnostic firms are supporting innovation and accessibility.

Future prospects for the market remain strong with continuous investments in research and development. The expansion of point-of-care testing and home-based diagnostic kits is expected to improve patient convenience and accessibility. Artificial intelligence-enabled diagnostic solutions are likely to enhance precision and predictive capabilities. Emerging economies in Asia-Pacific and Latin America present significant growth opportunities. Overall, the market is poised for sustained long-term growth supported by technological innovation and global health preparedness initiatives.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments)
  • Consumables
  • Services

By Sample

  • Saliva
  • Nasopharyngeal Swabs (NPS)
  • Anterior Nasal Region
  • Blood
  • Others

By Application

  • COVID-19
  • Influenza
  • Respiratory Syncytial Virus (RSV)
  • Tuberculosis
  • Streptococcus Testing
  • Other Respiratory Disease Testing

By Technology

  • Immunoassay
  • Molecular Diagnostics
  • Microbiology
  • Other Technologies

By End Use

  • Hospitals
  • Diagnostic Laboratories
  • Physician Offices
  • Others

COMPANIES PROFILED

  • Abbott, Thermo Fisher Scientific Inc, Koninklijke Philips NV, F HoffmannLa Roche Ltd, BD, bioMrieux SA, BioRad Laboratories Inc, Quidel Corporation, Siemens Healthcare GmbH, Danaher, Qiagen
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Instruments (Imaging Tests, Respiratory Measurement Devices, Other Instruments) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY SAMPLE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Sample
  • 5.2. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Nasopharyngeal Swabs (NPS) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Anterior Nasal Region Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. COVID-19 Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Influenza Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Respiratory Syncytial Virus (RSV) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Tuberculosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Streptococcus Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.7. Other Respiratory Disease Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Technology
  • 7.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Molecular Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Microbiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY END USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End Use
  • 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Physician Offices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product
    • 9.2.2 By Sample
    • 9.2.3 By Application
    • 9.2.4 By Technology
    • 9.2.5 By End Use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product
    • 9.3.2 By Sample
    • 9.3.3 By Application
    • 9.3.4 By Technology
    • 9.3.5 By End Use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product
    • 9.4.2 By Sample
    • 9.4.3 By Application
    • 9.4.4 By Technology
    • 9.4.5 By End Use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product
    • 9.5.2 By Sample
    • 9.5.3 By Application
    • 9.5.4 By Technology
    • 9.5.5 By End Use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product
    • 9.6.2 By Sample
    • 9.6.3 By Application
    • 9.6.4 By Technology
    • 9.6.5 By End Use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL INFECTIOUS RESPIRATORY DISEASE DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Abbott
    • 11.2.2 Thermo Fisher Scientific Inc
    • 11.2.3 Koninklijke Philips N.V
    • 11.2.4 F. Hoffmann-La Roche Ltd
    • 11.2.5 BD
    • 11.2.6 BioMAfA(C)Rieux SA
    • 11.2.7 Bio-Rad Laboratories Inc
    • 11.2.8 Quidel Corporation
    • 11.2.9 Siemens Healthcare GmbH
    • 11.2.10 Danaher
    • 11.2.11 Qiagen